STAT+: Still hoping for looser FDA rules, Regeneron says it will test durable antibody for Covid

SAN FRANCISCO — For months, drugmakers have been pleading with regulators to lower the bar for authorizing antibody drugs for Covid. The virus, they noted, had evolved fast enough to…

Click to view original post